Austrian Agency for Health and Food Safety (AGES) has issued GMP certification to Shilpa Medicare’s Unit 4, Jadcherla, Telangana. The said unit was inspected from January 22, 2024 to January 26, 2024. The previous EU - GMP inspection for this facility was in January 2020.
This unit of Shilpa Medicare is engaged in the manufacture, testing and distribution of sterile Injections and non-sterile tablets and Capsule finished dosage forms in the US, Europe and rest of the world markets. This inspection will facilitate continued supply of medicines for commercial distribution to various countries of the European Union from this unit.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
